Divis Laboratories Profit & Loss Annual

Trade
BSE: 532488 | NSE: DIVISLAB | ISIN: INE361B01024 | Sector: Biotechnology & Drugs
5,509.65 +14.00 (0.25%)Updated : 16 Sep 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 7,845.007,767.518,959.836,969.40
Total Revenue 7,845.007,767.518,959.836,969.40
Costof Revenue Total 3,129.003,688.793,489.232,750.83
Gross Profit 4,716.004,078.725,470.604,218.57
Selling/ General/ Admin Expenses Total 1,094.001,654.401,541.481,306.00
Depreciation/ Amortization 378.00343.18311.51255.59
Other Operating Expenses Total 1,417.00---
Total Operating Expense 6,018.005,741.745,387.354,354.71
Operating Income 1,827.002,025.773,572.482,614.69
Interest Inc( Exp) Net- Non- Op Total 270.003,389.701,091.80551.30
Other Net 309.005.023.892.18
Net Income Before Taxes 2,163.002,368.633,683.502,666.04
Provisionfor Income Taxes 563.00545.25723.05681.75
Net Income After Taxes 1,600.001,823.382,960.451,984.29
Net Income Before Extra Items 1,600.001,823.382,960.451,984.29
Net Income 1,600.001,823.382,960.451,984.29
Income Availableto Com Excl Extra Ord 1,600.001,823.382,960.451,984.29
Income Availableto Com Incl Extra Ord 1,600.001,823.382,960.451,984.29
Diluted Net Income 1,600.001,823.382,960.451,984.29
Diluted Weighted Average Shares 26.5526.5526.5526.55
Diluted EPS Excluding Extra Ord Items 60.2768.69111.5274.75
DPS- Common Stock Primary Issue 30.0030.0030.0020.00
Diluted Normalized EPS 60.2768.72111.5874.91
Research Development -553.70451.30422.90
Gain( Loss)on Saleof Assets --11.30-20.50-59.60
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,773.70+33.60(1.23%)
405.75+4.50(1.12%)
1,650.65+16.20(0.99%)
7,376.95-220.05 (-2.90%)
2,851.00-82.95 (-2.83%)
HomeMarketsPremiumInstant LoanMint Shorts